Assignee
SHANGHAI LUMOSA THERAPEUTICS CO LTD
CN·3 granted patents·4 pending applications·5 citations·filing 2013–2023
Top patents by PatentIndex Score
7 records- 0178US10806798B2Compound with effects of thrombolysis, free radical scavenging and thrombus-targetingSHANGHAI LUMOSA THERAPEUTICS CO LTD·Filed 2018·Granted Oct 20, 2020·2 cites·6 claims
- 0278US10351594B2Process for preparing compounds having triple activities of thrombolysis, antithrombosis, and radical scavengingSHANGHAI LUMOSA THERAPEUTICS CO LTD·Filed 2018·Granted Jul 16, 2019·3 cites·2 claims
- 0376US2023312644A1Compounds having triple activities of thrombolysis, antithrombotic and radical scavengingSHANGHAI LUMOSA THERAPEUTICS CO LTD·Filed 2023·Application pending·0 cites
- 0468US2021355163A1Compounds having triple activities of thrombolysis, antithrombotic and radical scavengingSHANGHAI LUMOSA THERAPEUTICS CO LTD·Filed 2021·Application pending·0 cites
- 0559US2020055895A1Compounds having triple activities of thrombolysis, antithrombotic and radical scavengingSHANGHAI LUMOSA THERAPEUTICS CO LTD·Filed 2019·Application pending·0 cites
- 0653US9890193B2Compounds having triple activities of thrombolysis, antithrombosis, and radical scavenging, synthesis, and use thereofSHANGHAI LUMOSA THERAPEUTICS CO LTD·Filed 2015·Granted Feb 13, 2018·0 cites·6 claims
- 0740US2015290339A1Novel compound with effects of thrombolysis, free radical scavenging and thrombus-targeting as well as preparation method and use thereofSHANGHAI LUMOSA THERAPEUTICS CO LTD·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHANGHAI LUMOSA THERAPEUTICS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →